Elismetrep

DB15287InvestigationalSmall molecule

Elismetrep is under investigation in clinical trial NCT02429102 (A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-8554 in Healthy Subjects).

Mechanism: Pharmacologically active on Transient receptor potential cation channel subfamily M member 8
Curator reviewed
Formula / weight: C₂₇H₂₁F₃N₂O₅S · 542.53 g/mol (avg)
Code names: MT-8554

Resolves to

Compound

UNIIKIB8V5UR7DCAS1400699-64-0ChEMBLCHEMBL3682589

Structure

InChIKeyCWEFDWIKLABKBX-UHFFFAOYSA-NSMILESOC(=O)C1=CC=C(C=C1)S(=O)(=O)N(CC1=CC=C(OC(F)(F)F)C=C1)C1=NC=C2C=CC=CC2=C1C1CC1

Targets

Q7Z2W7TRPM8

What you can answer from here — as of June 19, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

10Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Elismetrep, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account